Blog

Results from NAT Initiative show promising, meaningful clinical improvements in newborn healthcare

The NAT Initiative Executive Summary delivers background and overview information, results, key findings, and lessons learned from the Newborn Admission Temperature initiative.

The Newborn Admission Temperature (NAT) Initiative was the first TCHMB project to measure outcomes disaggregated by race and ethnicity from hospitals, an important step toward understanding and reducing disparities in perinatal healthcare and health outcomes in Texas. Of particular note are the following findings:

  • The findings of decreased hypothermia among NICU admissions — in NICUs that consistently reported race and ethnicity disaggregated data — highlight the potential of statewide initiatives for improvement in settings caring for the most vulnerable newborns.

  • The NAT Initiative identified significant disparities in hypothermia incidence, with newborns of non-Hispanic Black mothers having approximately twice the incidence compared to newborns of non-Hispanic White mothers.

More key findings, data, and conclusions & future directions are available in the NAT Initiative Executive Summary.

Q&A: Dr. Charleta Guillory, TCHMB Chair

Dr. Charleta Guillory is the current chair of the Texas Collaborative for Healthy Mothers and Babies (TCHMB). I sat down with Dr. Guillory to learn more about her achievements, passion for infant and mother health, and her vision for TCHMB during her tenure as chair. 

Dr. Guillory was selected as chair after serving as co-chair of the neonatal committee for 6 years. She is a Professor of Pediatrics in the Section of Neonatology at Baylor College of Medicine and Director of the Texas Children's Hospital Neonatal-Perinatal Public Health Program.

1. Please describe your education, specifically your medical education.

I was one of the first 2 Black female graduates (out of a mere 4 total women in the entire program) who completed my medical education at Louisiana State University Medical School in New Orleans, earning my MD degree in 1974. Following this, I completed a Pediatric Residency at the University of Colorado Medical Center and Louisiana State University from 1975 to 1978. I then pursued a Neonatal-Perinatal Medicine Fellowship at Baylor College of Medicine's Department of Pediatrics in Houston from 1978 to 1981, and I am board certified in both pediatrics and neonatal-perinatal medicine.

My education also includes leadership and national policy training through the Gallup Leadership Institute and the American Political Science Association's Congressional Fellowship Program. I was 1 of 6 physicians in the United States to receive the Robert Wood Johnson Health Policy Fellowship from the National Academy of Science and Institute of medicine, where I served as a legislative assistant in the United States Senate (office of Senator John B. Breaux, LA) promoting both health policy legislation and programs.

Additionally, I earned a Master of Public Health from UTHealth Houston School of Public Health in 2015, completing a thesis on the High Rate of Prematurity in African-American Women in Houston, Texas and focusing on efforts to advance programs and policies that improve neonatal health outcomes.

2. Please describe your career experience within medicine.

My very first job after completing my fellowship in 1981 was co-director of the Woman's Hospital of Texas NICU, transitioning the nursery from Level II to Level III. In addition, I directed the Texas Children's Hospital Level II Nursery for 21 years, where I established admission and discharge guidelines and coordinated quality improvement projects. My leadership experience included working with multidisciplinary teams of neonatologists, nurse practitioners, fellows, residents, medical students, and nursing staff.

Throughout my career in medicine, I have held numerous key roles that have significantly impacted maternal and child health. As the Director of the Neonatal-Perinatal Public Health Program and the immediate past Director of the Texas Children's Hospital Level II Nursery.  I have managed the care of infants with complications such as prematurity, birth defects, and metabolic disorders, overseeing transfers from across Texas and beyond.

Additionally, my training through the Robert Wood Johnson Health Policy Fellowship, Congressional Fellowship, and Gallup Institute Leadership Course has equipped me to influence healthcare policy. As Chair of the March of Dimes State Prematurity Campaign and the State Advocacy and Government Affairs committee, I have led statewide initiatives to reduce premature births and developed materials for legislative advocacy. I also currently direct the Patient Advocacy Elective in Pediatrics at Baylor College of Medicine, further contributing to my extensive career in educating others in neonatal healthcare.

I also chaired the Texas Department of State Health Services (DSHS) Newborn Screening Advisory Committee — championing the increase of the number of newborn screens being done by the state to help decrease infant mortality — and served 10 years on the Texas Health and Human Services (HHS) Perinatal Advisory Council (PAC) — designating levels of neonatal and maternal care.

Recently, I was appointed to serve on the Food and Drug Administration (FDA) Pediatric Advisory Committee and was appointed to the American Academy of Pediatrics (AAP) National Committee on Fetus and Newborn. I served as President of the Texas Pediatric Society (TPS) of the American Academy of Pediatrics for 2021 and now serve as the TPS/AAP Chapter Chair President. My commitment to improving the health of infants led to the Secretary of Health and Human Services appointing me to serve on the HRSA Advisory Committee on Infant and Maternal Mortality.

Still today, I continue to work in the Neonatal Intensive Care Unit Level IV and serve on the ECMO team. My advocacy for improving maternal and infant health, especially for vulnerable populations, has been a central theme in my work. I have been dedicated to reducing infant mortality and eliminating disparities in health outcomes based on socioeconomic, racial, and ethnic factors.

3. How did you become involved with TCHMB?

I started as a member of the Expert Panel in 2011 advising Healthy Texas Babies, the state infant mortality reduction initiative housed at DSHS, and I continued as a member of TCHMB at its inception, which began officially operating as the state perinatal quality collaborative in 2013. As the group continued to evolve, I served as the Co-Chair of the Neonatal Standing Committee of the Executive Committee for over 6 years.

4. What does it mean to you to be TCHMB Chair?

Every job that I have, or have had, I approach with commitment, service, and an opportunity to improve the lives of others. I bring to TCHMB a vast variety of experiences/preparation to work in a community of like-minded experts to effect positive change. I feel both humbled and proud to have the privilege to be part of this awesome team.

I remain committed to identifying the social determinants of health and their effects on the maternal and infant population before and after NICU admission. As a leader in the field of neonatology at the city, state, and national levels, my mission is to identify and implement solutions for these adverse determining factors that impact infant and maternal health.

In my tenure as TCHMB Chair, I aim to achieve several key goals that align with best practices in maternal and child health. Firstly, I intend to reduce infant mortality rates and improve overall infant and child health outcomes, particularly focusing on addressing health disparities. By enhancing access to high-quality care for vulnerable populations, I hope to create more equitable health outcomes for all Texas families.

Secondly, I plan to implement and support quality improvement initiatives across neonatal and perinatal care units. This includes developing and refining guidelines and protocols to ensure consistent, evidence-based care for premature and critically ill infants. Collaborating with healthcare professionals, I will promote best practices and foster a culture of continuous improvement.

Lastly, I hope to build collaboration and knowledge sharing among healthcare providers, researchers, and policymakers. By creating a robust network of partners, we can drive innovation and ensure that Texas remains a leader in neonatal and perinatal care.

Through these efforts, I aspire to make a lasting impact on the health and well-being of mothers and infants, contributing to a healthier future for Texas families and continuing to make the work of TCHMB impactful.

Written by Kirsten Handler, Communication Specialist at UTHealth Houston School of Public Health in Austin. 

TCHMB is funded by the Texas Department of State Health Services.

Understanding Preeclampsia: A Guide for Preeclampsia Awareness Month

May is Preeclampsia Awareness Month, an annual event that promotes improved healthcare practices as they relate to preeclampsia. Patients are encouraged to share their experiences, and researchers, clinicians, and legislators are encouraged to prioritize preeclampsia research. The Preeclampsia Foundation, which leads a month-long campaign about the hypertensive disorder every May, named the 2024 theme ‘Predict Prevent Prevail.’ 

Texas Collaborative for Healthy Mothers and Babies (TCHMB) — the state’s perinatal quality collaborative that comprises healthcare providers, scientists, hospitals, state agencies, advocates, and insurers — developed Understanding Preeclampsia: A Guide for Preeclampsia Awareness Month to support improved care and outcomes for preeclampsia patients in Texas.  

Defining Preeclampsia 

Preeclampsia is a life-threatening condition that affects 5-8% of pregnant patients, characterized by elevated blood pressure (BP) and, at times, elevated protein in the urine (proteinuria). It may be accompanied by other symptoms, including chest pain, abdominal pain, liver problems, headaches, and changes in vision.  

Alone, each of these symptoms does not indicate preeclampsia, but it’s important for pregnant patients to report these symptoms and any existing conditions to their healthcare provider. Some conditions put pregnant patients at a higher risk of developing preeclampsia: 

  • A woman who has never delivered a baby 

  • Type 1 or Type 2 diabetes 

  • History of hypertension 

  • 35 years or older 

  • Teenager (under 20) 

  • Chronic medical conditions, including kidney disease or Lupus 

  • Preeclampsia/hypertension in a previous pregnancy 

  • Twin pregnancy 

Diagnosing Preeclampsia

Providers will diagnose preeclampsia when a patient meets the following conditions: 

  • Been pregnant for at least 20 weeks 

  • Reported systolic BP of 140 or higher -or- diastolic BP of 90 or greater 

  • On at least 2 occasions that are at least 4 hours apart

A diagnosis of preeclampsia can be given with or without the presence of proteinuria. 

Treating Preeclampsia 

The course of action following a preeclampsia diagnosis depends on the stage of pregnancy. In most cases, a patient confirmed to have BP greater than 140/90 will be sent for an initial evaluation at a hospital, where providers will monitor BP, collect laboratory tests including a urine test for proteinuria, and assess for symptoms of preeclampsia.

Treatment for Preeclampsia Based on Stage of Pregnancy

To prevent preeclampsia in patients at risk, doctors will prescribe a low-dose aspirin at around 16 weeks of gestation.

Developing Recognition and Response to Postpartum Preeclampsia in the Emergency Department (PPED), a TCHMB Quality Improvement (QI) Project 

11% of pregnancy-related deaths are related to preeclampsia/eclampsia, with 50% of those deaths occurring in the first six weeks (42 days) after delivery, according to the Texas Maternal Mortality and Morbidity Review Committee and Department of State Health Services Joint Biennial Report 2022. Consequently, it is important for the public to recognize preeclampsia symptoms, which can occur not only during pregnancy but also during the postpartum period. 

Based on this data — and because so many patients who experience preeclampsia symptoms visit the emergency room — TCHMB developed the PPED QI project. This initiative aims to reduce maternal morbidity and mortality related to severe hypertension in postpartum patients by increasing the collaboration between obstetric and emergency departments with: 

  • Enhanced screening for postpartum status 

  • Education on diagnosis, treatment, and follow-up care in the emergency department 

Latest Research and Future Directions 

Research into preeclampsia has recently focused on understanding its underlying causes, with particular attention to the placenta’s role. While the exact cause remains elusive, ongoing studies are investigating inflammatory components and antibodies that may contribute to the condition. Experts predict that within the next decade, advancements in this area will provide valuable insights into prediction and prevention strategies. 

Clinical Review 

Special thanks to the following healthcare professionals for contributing their expertise to this article: 

  • James Hill, MD, the Obstetrics Committee Co-Chair for TCHMB and the Division Chief for the Division of Maternal-Fetal Medicine at Baylor College of Medicine/The Children’s Hospital of San Antonio. Previously, he was a Field Artillery officer and retired Colonel in the United States Army and a mathematics professor at West Point. 

  • Susan Dimitrijevic, BSN, RNC-NIC, the Senior Nurse Program Manager for TCHMB. For the past 25 years, she has focused her nursing career on Neonatal Intensive Care, caring for critically ill infants and their families. Before joining TCHMB, she was the Neonatal Program Manager and Clinical Nurse Manager of the Level NICU Transport team at Dell Children’s Medical Center. 

Written by Kirsten Handler, Communication Specialist at UTHealth Houston School of Public Health in Austin. 

TCHMB is funded by the Texas Department of State Health Services. 

Family and Child Health Expertise Joins UTHealth Houston School of Public Health

Family and Child Health Expertise Joins UTHealth Houston School of Public Health

The Population Health team was established in 2015 to address the needs of family and child health through partnerships with and funding from state agencies.

Start Planning How to Integrate Social Determinants of Health at Your Hospital

More than 400 people attended the 2023 TCHMB Summit, which focused on Social Determinants of Health (SDoH) and its Impact on Maternal and Neonatal Outcomes. A majority of attendees reported that one of the major objectives was to take actionable quality improvement strategies back to hospitals, according to the post-summit survey.

During the summit, TCHMB provided an action plan and worksheet to get people thinking about the steps to make this happen. Even if you didn’t attend the summit, you can use these resources as a framework for building your plans to address SDoH at your hospital. It helps you list goals, milestones and think about target specific outcomes, as well as identify who in your organization can help you get there.

Be sure to check out the 2023 summit webpage for a copy of the slides if you need them to get your action plans started!

Download the summit pre-session worksheet.

Download the post-summit action plan.

TCHMB Welcomes Four New Executive Committee Members

Read more about why they are a good fit to lead TCHMB’s efforts for quality care, equity and safety for mothers and babies.

 

Vice-Chair of Executive Committee: Charleta Guillory, MD, MPH, FAAP

Professor of Pediatrics, Baylor College of Medicine

Why are you interested in serving as Vice Chair for TCHMB?

“As the Director of the Neonatal-Perinatal Public Health Program, and as immediate past Director of the Texas Children's Hospital Level II Nursery, I see firsthand, as a pediatrician and neonatologist, complications of prematurity, birth defects and metabolic disorders. These complications require many infants to be transferred into our center from across the state of Texas and beyond its borders.

I have always been an advocate to improve the health of mothers and babies and have recognized that vulnerable populations have poorer outcomes. I have dedicated my life, both professionally and personally, to decreasing infant mortality, improving infant and child health, and eliminating socio-economic, racial and ethnic disparity in maternal, infant and child health outcomes. Serving as Chair of the TCHMB is another opportunity to make an impact on the lives of Texas families. I bring to this committee a voice of experience and a voice of compassionate concern.”

 

Neonatal Committee Co-Chair: Gillian Gonzaba, NNP

Neonatal Nurse Practitioner, Associate Director for High Reliability/Patient Safety and Simulation, Pediatrix Medical Group, San Antonio

What do you hope to accomplish as Neonatal Co-Chair?

“I would like to work to improve access to care and diversity for all mothers across the state. With improved access to care, there is the potential for improved outcomes for our patients when they are born.”

 

New At-large EC Member: Jasmine Farrish CNM, MSN, MPH

Nurse Supervisor- Nurse Family Partnership University of Texas at Tyler Health Science Center

What strengths or unique perspectives do you bring to the Executive Committee?

“I have 10 years of maternal child experience in various settings mostly outside of the hospital setting. I believe the community perspective is important piece to serving the entire family in additional to addressing hospital policies. Serving families within the home as a nurse home visitor shed light on the importance of addressing the entire family unit in order to impact change.”

 

New At-large EC Member: Sonal Zambare, MD

Assistant Professor; Obstetric Anesthesiology, Baylor College of Medicine

What strengths or unique perspectives do you bring to the Executive Committee?

“As a fellowship trained anesthesiologist from a busy practice, I bring my experience in successfully managing many high risk, and complicated pregnant patients. I am the anesthesiologist on the MOM grant (a grant from CMS for helping pregnant patients with substance use disorders, especially opioids), which has broadened my reach to the community. I am the lead on establishing the Enhanced Recovery after Cesarean protocol at Ben Taub Hospital, which has been a successful program.”

Hospitals Are Moving the Needle on Data Collection

The Newborn Admission Temperature (NAT) Project aims to improve the proportion of newborn babies with normal temperatures. We completed more than one year of data collection and early this fall released example evidence-based guidelines that hospitals can choose to use.

The NAT project has also produced benefits for implementing future QI projects and initiatives. For example, we asked hospitals to rate the statement “Being part of the NAT project helps us better report data by race and ethnicity.”

The proportion of hospitals that reported that their participation in the NAT project is helping them improve reporting of data stratified by race and ethnicity increase over the course of the initiative. In the first two data reporting cycles, only about one third (33-38%) of hospitals agreed with this statement, compared to nearly half (47%) of hospitals by the most recent data reporting cycle. (Click here to view the graph.)

Looking at the critical factors and conditions (challenges or barriers) that ensure effective practices are carried out and sustained for future practices is part of implementation science and it is equally as important as improving health outcomes for several reasons:

  • Routinely reporting race/ethnicity through the NAT project might have a trickle-down effect as hospitals begin to build these processes within their own systems and projects; and

  • The NAT project is the first TCHMB project that has documented outcomes by race and ethnicity and has set the stage for future TCHMB projects to do the same.  This is a strategy that cannot be understated given the disparities in maternal and neonatal outcomes in Texas.

Texas’ perinatal population is diverse and rapidly growing, and despite considerable improvement efforts, disparities in several key perinatal health indicators persist or have widened. Black mothers in Texas had higher rates of severe maternal mortality (SMM) than mothers of any other race or ethnic group over the past decade, and this disparity has widened since 2016.

High-quality, stratified data including race and ethnicity, at a minimum, can help reveal how different subpopulations are faring and track efforts to advance equity in health care and health outcomes. In this way, through its data collection process and through the participation of hospitals, the NAT project is breaking barriers while also working to eliminate disparities in perinatal health outcomes.

 

Read more about the new CDC grant that will work towards eliminating disparities in Texas.